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ABSTRACT
Introduction: Pharmacotherapy is the main therapeutic resource for the management 
of diseases. However, the number of drugs prescribed, dose frequency, and mode of 
administration can make the treatment more complex and influence treatment outcomes. 
The aim of this study was to measure the complexity of prescribed medication regimens 
in primary health care (PHC) services in Ribeirão Preto, Brazil.
Methods: This cross-sectional study included 1,009 participants: 889 from primary 
health units and 120 from family health units in Ribeirão Preto, Brazil. Treatment 
complexity was assessed using the Medication Regimen Complexity Index (MRCI).
Results: MRCI mean scores were 12.5 points (SD = 9.3) and dose frequency was the 
major contributor to increase the score. The complexity of pharmacotherapy showed a 
significant correlation with the number of prescribed medications (r = 0.93, p < 0.01), 
but not with patients’ age (r = 0.28, p < 0.01). There is also no difference in complexity 
between the sexes (p = 0.83) and the types of primary health care service (p = 0.31). 
An analysis of variance revealed that patients with lower levels of education receive 
more complex prescriptions (p < 0.01).
Conclusions: The pharmacotherapy prescribed in PHC services from Ribeirão Preto, 
Brazil is complex, and there is a need to concentrate efforts and adopt strategies to 
simplify drug prescription without compromising patient’s clinical status.
Keywords: Primary health care; drug prescriptions; drug therapy; medication regimen 
complexity
Medications are certainly essential for managing the health-disease 
process. Drug therapy is the main therapeutic resource to cure and control 
diseases, but medication use is not exempt from risks and may lead to Drug 
Realted Problems (DRP)1-3.
Currently, the use of multiple medications is a multifactorial problem involving 
the growing development of new medications and health technologies, the 
power of marketing promoted by the pharmaceutical industry, the presence 
of a culture of medicalization in health professional training, and population 
demand for drug consumption and self-medication2,4. In addition, the worldwide 
epidemiological profile has been changing over the years, resulting in population’s 
aging and consequently in the predominance of non-communicable chronic 
health conditions and in sequelae arising from the aging process, which in 
turn increase the need for multiple treatments5. The simultaneous use of 
several medications by the same individual is known as polypharmacy, a 
practice that exposes patients to higher complexity therapies and increases 
the risk for DRP6.
Some components of therapeutic regimens, such as number of prescribed 
drugs, dose frequency, and administration instructions, have an influence on 
treatment outcomes7. This is because these factors make drug administration 
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a costly, time consuming, and complicated activity, 
thus increasing treatment complexity and hindering 
its compliance. Moreover, increased prescription 
complexity raises susceptibility to drug interactions, 
adverse reactions, development of comorbidities, and 
decreased quality of life8. Thus, the complexity of the 
prescribed treatment may influence its adherence9-11.
The investigation of drug therapy complexity 
enables health professionals to estimate the ease 
(or difficulty) in treatment adherence, to determine 
the elements that most contribute to increased 
complexity, and to implement strategies to address 
these elements and simplify therapy2,11,12.
The aim of the present study was to measure the 
complexity of drug therapy prescribed to patients 
treated by primary health care (PHC) services in the 
city of Ribeirão Preto, Brazil, in order to determine 
the complexity profile of patients’ prescriptions and 
identify the main factors that contribute to increase 
treatment complexity.
METHODS
This was a descriptive cross-sectional study 
conducted in the city of Ribeirão Preto, Brazil, from 
September 2014 to April 2015. The study was approved 
by the institution’s Research Ethics Committee.
Sample size was calculated by stratified sampling13. 
Health facilities were grouped into eight strata 
according to health district and to primary health care 
provided (primary care unit [PCU] or family health 
unit [FHU]). This strategy allowed for the recruitment 
of a heterogeneous but representative sample.
A confidence coefficient of 95% and an absolute 
accuracy of 3% were considered for ratio estimation. 
In order to maximize variance, this ratio was established 
as 50% in each stratum, yielding an estimated 
sample size of 1,052 subjects. Sample allocation 
was proportional to the mean number of medical 
appointments/month in each stratum. Two PCUs 
and two FHUs of each stratum were randomly drawn 
for data collection; thus, ten UBS and five USF were 
selected to participate in the research (some health 
districts did not contain FHU).
Participants’ eligibility criteria were: age 18 or older; 
attendance to the public health system in Ribeirão 
Preto, considering PCUs and FHUs; being prescribed 
with at least one medication. This study excluded 
individuals unable to communicate appropriately, 
those who were prescribed in the private health 
insurance system or whose prescriptions lacked 
dosage for one or more medications.
Participants were selected by non-probability 
sampling. Public health users were approached 
while they were waiting for drug dispensing at the 
PCU/FHU pharmacy or after medical appointment 
if the unit did not have a community pharmacy. 
The participants authorized researchers to make a copy 
of drug prescription and provided sociodemographic 
information.
The complexity of the prescribed drug therapy was 
assessed using the Medication Regimen Complexity 
Index (MRCI)2, an instrument that was translated 
and validated into Portuguese and are based on the 
actions required to administer medications. The MRCI 
is grouped into three sections:
• Section A: information on dosage forms;
• Section B: information on dose frequency;
• Section C: additional information that the patient 
should take into consideration for the appropriate 
drug administration, such as drug specific time, 
concomitant use with food, drug dissolution in 
water2.
Each section is scored based on treatment 
complexity (the higher the score, the higher the 
complexity) and the overall complexity index is 
obtained by adding the scores of the three sections 
for each prescribed drug2.
Prescriptions that lacked drug dosage for at least 
one medication (prescription error) were excluded 
from calculation. Polypharmacy was characterized 
according to the criteria established by Lucchetti et al.6 
as the concomitant use of five or more medications.
Data were codified and stored in a Microsoft Office 
Excel 2007 spreadsheet and information was entered 
twice to analyze consistency. Statistical analyses 
were conducted using the Statistical Analysis System 
(SAS) software, considering a significance level of 
α= 0.05 and a confidence interval of 95% (95CI).
RESULTS
Of the collected drug prescriptions, 43 lacked drug 
dosage for at least one medication and were thus 
excluded from the study. Hence, below are results for 
the drug therapy complexity of 1,009 prescriptions, 
of which 889 came from PCUs and 120 from FHUs.
Sociodemographic Characteristics
Among the participants, 76.8% were female, and mean 
age was 54.1 years (standard deviation [SD] = 17.4). 
There was a predominance of subjects with white 
skin (73.5%) and low educational level, since more 
than 50% of participants did not conclude primary 
education. One of the main criteria to define poverty 
in Brazil establishes that an individual is considered 
poor if his/her per capita income is equal to or lower 
than half minimum wage14. According to this definition, 
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27.3% of our sample is poor. Mean monthly per capita 
income was BRL 701.37.
Table 1 presents the sociodemographic characteristics 
of the population studied.
Complexity of the Prescribed Drug Therapy
Mean scores for drug therapy complexity was 
12.5 points (SD = 9.3), with a maximum of 67.5 and 
a minimum of 2.0 points (Table 2).
Table 3 shows the distribution of drug prescriptions 
according to complexity scores, revealing that nearly 
the half of the collected prescriptions have a complexity 
index above 10 points.
As for index sections, it was found that section B 
(dose frequency) was the major contributor to 
increase drug therapy complexity, whereas section A 
(dosage form) was the one that less contributed to 
this increase (Table 4).
Student t tests were conducted to compare mean 
complexity scores obtained in PCUs and FHUs, either 
overall scores and those of each section. No differences 
were observed in MRCI scores between the two 
primary health care models (Table 4).
The most prescribed dosage form was 
capsules/tablets, followed by liquid formulations. 
The most common dose frequency was “once daily”, 
followed by “every 12 hours”. The most provided 
additional information was “taking/using the medication 
at a specific time” and “relation to food”.
A total of 3,838 medications were prescribed in the 
1,009 prescriptions analyzed, yielding in a average of 
four medications per prescription (SD = 2.8). Among 
study participants, 33.3% were receiving polypharmacy. 
The relationship between number of medications 
and treatment complexity was assessed using the 
Pearson’s correlation coefficient. This assessment 
yielded an r of 0.93 (p < 0.01); thus, there was a 
very strong positive correlation between number of 
medications and drug therapy complexity. Based on 
these data, it is possible to assume that the higher 
the number of medications, the higher the complexity 
of treatment.
The highest complexity score (67.5 points) was 
obtained by one of the participants with the highest 
number of prescribed medications (n = 20). Similarly, 
the lowest complexity score (two points) was also 
proportional to the lowest number of medications 
Table 1: Sociodemographic characteristics of the population 
studied.
Variable n %
Sex
Male 234 23.2
Female 775 76.8
Age (years)
18-40 256 25.4
41-60 327 32.4
> 60 426 42.2
Skin color (ethnicity)
White 742 73.5
Black 108 10.7
Asian descent 6 0.6
Mixed race† 153 15.2
Native Brazilian 0 0
Educational level
Never attended school 54 5.4
Incomplete elementary school 470 46.6
Complete elementary school 171 16.9
Incomplete high school 82 8.1
Complete high school 173 17.1
Incomplete higher education 23 2.3
Complete higher education 33 3.3
Graduate degree 3 0.3
Per capita income
Below 500 BRL 427 42.3
Below 1,000 BRL 437 43.3
Below 1,500 BRL 99 9.8
Above 1,500 BRL 46 4.6
Occupational status
Has a job 345 34.2
Works and studies 12 1.2
Retired or pensioner 388 38.5
Unemployed 33 3.3
Studies 4 0.4
Not employed 227 22.5
Marital status
Single 165 16.4
With a partner 559 55.4
Divorced/separated 118 11.7
Widowed 167 16.6
Total 1,009 100
Table 2: Results for complexity analysis of drug prescriptions.
Primary 
care units
Family 
health 
units
Total
Number of medical 
prescriptions
889 120 1,009
Range of MRCI in 
the sample
65.5 45.0 65.5
MRCI mean score 12.6  
(SD = 9.4)
11.8  
(SD = 8.3)
12.5
MRCI minimum 
score
2.0   2.0   2.0
MRCI maximum 
score
67.5 47.0 67.5
SD: standard deviation; MRCI: Medication regimen complexity 
index.
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(n = 1). These findings confirmed the previously 
found correlation between number of medications and 
complexity scores. However, there were differences 
in MRCI scores between patients using the same 
number of medications, which demonstrates the 
significance of other factors in the calculation of 
the index. MRCI mean scores and their dispersion 
measures, considering a 95% confidence interval, 
show an overlap of results (Table 5), which confirms 
that treatments with the same number of medications 
may have different levels of complexity. It can also be 
observed that dispersion increase with the increase 
in the number of medications.
The relationship between participants’ age and 
prescription complexity as assessed by the Pearson’s 
correlation coefficient yielded an r of 0.28 (p < 0.01). 
This value evidences a negligible correlation, i.e., 
it is not possible to state that treatment complexity 
increases with age. Complexity scores were similar 
across different ages.
With regard to sex, MRCI mean scores were 
12.4 points (SD = 7.9) for males and 12.6 points 
(SD = 9.6) for females. According to the Student 
t test, no differences were observed in drug therapy 
complexity between the sexes (p = 0.83).
The ANOVA test yielded a p-value of < 0.01 for 
the association between participants’ educational 
level and MRCI scores, suggesting that variance for 
complexity is different across the educational levels. 
Post hoc comparisons were required to investigate 
differences between each pair of educational level 
groups. Thus, the Tukey test revealed differences 
between all pairs of educational level groups, except 
between the high school education group and the 
higher education group.
Table 5: Number of medications and drug therapy complexity.
No. of 
medications n
MRCI mean 
score 95%CI
1 215 4.2 2.5-5.9
2 210 7.4 5.1-9.7
3 146 10.3 7.3-13.3
4 116 12.5 9.2-15.8
5 99 16.1 11.9-20.3
6 62 17.9 14.3-21.5
7 56 21.3 16.9-25.7
8 34 24.2 18.8-29.6
9 29 29.1 22.8-35.4
10 14 32.5 27.9-37.1
11 9 35.9 29.8-42.0
12 6 34.6 29.6-39.5
13 4 47.2 40.8-53.6
14 2 44.0 37.6-50.4
15 3 59.2 55.6-62.8
16 1 53.0 -
17 1 58.0 -
20 2 57.2 42.7-71.7
Total 1,009 12.5 3.2-21.8
95%CI: 95% confidence interval; MRCI: Medication Regimen 
Complexity Index.
Table 4: Results for the analysis of each section of the Medication Regimen Complexity Index (MRCI).
Primary care units Family health units Total p-value
Mean score SD Min Max Mean SD Min Max Mean SD Min Max P
Section A 2.3 2.0 1.0 15.0 2.1 2.1 1.0 15.0 2.3 2.0 1.0 15.0 0.48
Section B 6.2 5.0 0.0 23.0 5.9 4.3 0.0 17.0 6.2 5.0 0.0 23.0 0.44
Section C 4.1 3.6 0.5 30.5 3.8 3.1 1.0 23.0 4.1 3.6 0.5 30.5 0.24
Total MRCI 12.6 9.4 2.0 67.2 11.8 8.3 2.0 47.0 12.6 9.4 2.0 67.2 0.31
p-values for Student’s t-tests to compare means for primary care units and family health units; SD: standard deviation; Min: minimum; 
Max: maximum; Section A: information on dosage forms; Section B: information on dosage frequency; Section C: additional information that 
the patient should take into consideration for the appropriate drug administration; MRCI: Medication Regimen Complexity Index.
Table 3: Drug prescriptions from the primary health care system in Ribeirão Preto, Brazil, grouped according to drug 
therapy complexity.
MRCI score Primary care units Family health units TotalNo. of prescriptions % No. of prescriptions % No. of prescriptions %
< 5 points 172 19.3 19 15.8 191 18.9
5.5-10 points 273 30.7 49 40.8 322 31.9
10.5-15 points 193 21.7 23 19.2 216 21.4
15.5-30 points 207 23.3 23 19.2 230 22.8
30.5-45 points 34 3.8 5 4.2 39 3.9
> 45 points 10 1.1 1 0.8 11 1.1
Total 889 100 120 100 1,009 100
MRCI: Medication Regimen Complexity Index.
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DISCUSSION
The high prevalence of women at PHC services 
is a recurrent finding in scientific publications15-18, 
probably because women are knowingly more 
attentive to disease signs and symptoms and seek 
health services more often15,19.
The high prevalence of elderly in PHC services is 
also a common finding, since this population suffers 
from chronic health conditions and uses a great 
number of medications5,20.
Low socioeconomic level is a remarkable 
characteristic of our sample, as shown by the low 
income and low educational level observed in this 
study. The percentage of the Ribeirão Preto population 
considered as poor is 11.32%14, whereas 27.3% of 
our study population was classified as poor. This was 
an expected finding, because the present study 
excluded private health care users. The Brazilian 
Unified Health System (UHS) was designed exactly 
to provide health coverage to the poorest populations 
and reducing health service inequality5.
In reviewing the literature, no data was found 
on MRCI cut off points for high or low complexity 
prescriptions. However, the MRCI mean scores 
obtained in the present study was different from 
that of other studies assessing PHC patients, which 
found lower complexity scores. MRCI mean scores 
were 7.4 points in the study by Aldrigue et al.21 and 
7.7 points in the study by Fröhlich22. Our mean values 
were similar to that found by Obreli-Neto et al. et al. 
in a research that analyzed only elderly patients 
(13 points)23 who knowingly use a greater number of 
medications, due to their multiple diseases, chronic 
conditions, and physiological changes23. However, 
the present study did not find a correlation between 
prescription complexity and participants’ age; hence, 
it is not possible to state that our high MRCI mean 
score may be explained by the great number of 
elderly included in the sample.
Although MRCI scores were not significantly 
affected by age and sex, low educational level was 
indeed associated with more complex therapies. 
The same finding was observed by Acurcio et al. 
in Belo Horizonte, Brazil11. This may suggest that 
users with lower income and educational level 
have worse health conditions, resulting in more 
complex prescriptions and increased vulnerability to 
complications resulting from treatment complexity11.
It is worth noting that higher MRCI scores may 
be related to a high mean number of medications, 
since there is evidence that MRCI scores increase 
with the increase in the number of medications.
The average of four prescribed medications is 
higher that the number recommended by the World 
Health Organization, which defines that a mean number 
from 1.3 to 2.2 medications do not represent a trend 
towards polypharmacy24. Mean values obtained in 
studies conducted in PHC services in other Brazilian 
municipalities were much lower those reported in the 
present study, ranging from 1.8 to 2.5 medications22,25-28; 
therefore, a trend towards polypharmacy was found in 
PHC services in Ribeirão Preto. This is a concerning 
finding, because polypharmacy may increase drug 
therapy complexity and create a barrier to treatment 
adherence6,27.
It should also be noted that 33.3% of our study 
participants received polypharmacy. This value may 
be underestimated, since some studies established 
different definitions for polypharmacy6, with cutoffs as low 
as two or more medications, or divided polypharmacy 
into classes, such a minor polypharmacy (use of two 
to four medications) and major polypharmacy (use of 
five or more medications)29,30. Our criterion of choice 
for polypharmacy was use of five medications or 
more because we believe that the use of multiple 
drugs is often required and is beneficial for the 
treatment of individuals with several comorbidities; 
thus, the criteria for polypharmacy should not be so 
strict. Nevertheless, it is essential to avoid the use 
of multiple medications as much as possible, since 
polypharmacy compromise patient’s safety, increases 
prescription complexity, and predisposes to the 
occurrence of drug interactions and adverse events8.
Although the correlation between number of 
medications and treatment complexity has already 
been demonstrated, there is also evidence that 
treatments with the same number of medications may 
have different levels of complexity, which corroborates 
the idea that the number of medications is not the 
only responsible for treatment complexity. Dosage 
form, dose frequency, and other additional information 
should also be taken into account2,7.
Consistent with the literature22,31, this research 
found that dose frequency was the MRCI section 
that most contributed to drug therapy complexity, 
thus revealing that frequency of drug administration 
is equally important as the number of medications, 
because increased dose frequency enhances patients’ 
forgetfulness and the occurrence of medication errors2.
It may be hypothesized that the scores obtained 
in the additional information section of the instrument 
may be higher UHS users compared with private 
health care users; however, no studies have confirmed 
this hypothesis. This possibility may be explained by 
the restricted number of options in terms of doses 
and formulations provided in the lists of medications 
available in the UHS, which, in some situations, 
leads to the prescription of multiple doses of the 
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same medication at the same time, use of alternate 
doses, or splitting or dissolving pills.
Strategies should be adopted to reduce the 
number if daily doses and decrease drug therapy 
complexity without limiting the use of medications 
essential to treat patient’s disease. A possible 
strategy is prescribing extended-release medications 
and medications composed of two or more drugs, 
whenever available. It is important to demand the 
inclusion of this type of medication and of different 
dosage forms and dose options in the lists of essential 
medicines. Prescriptions should also be reassessed 
to evaluate the possibility of reducing dose frequency 
or the number of medications, according to patient’s 
disease and clinical status. Along with physicians, 
pharmacists are the most skilled professionals to 
assist in the implementation of these strategies, 
because they can provide valuable information for 
drug therapy and patient care and can also manage 
complex therapeutic regimens, detect and prevent 
DRP, reduce medication errors, and monitor treatment 
adherence1,32.
The complexity of the therapeutic regimens 
prescribed in FHUs is similar to that of regimens 
prescribed in PCUs. Treatment complexity seems to 
be more associated with characteristics of patients 
and drugs than with type of PHC service. However, 
the more comprehensive and humane care proposed 
by the Family Health Strategy may contribute to 
patient’s understanding of treatment and to rational 
drug management. Therefore, the health care team 
and users should be constantly in contact both before 
and during treatment so that patients can understand 
the importance of correct use of drugs32.
This study does not include medications prescribed 
by other levels of care or over-the-counter drugs. 
Hence, treatment complexity may be even greater.
The MRCI have proved useful for the overall 
assessment of drug prescriptions and for the identification 
and analysis of the factors that determine therapy 
complexity, because this index yields a quantitative 
measure of the components that may compromise 
pharmacotherapy adherence. Drug prescriptions to 
PHC users in Ribeirão Preto, Brazil, are complex 
compared with those of other municipalities, which 
may cause DRP and hinder treatment adherence. 
Health care professionals should concentrate efforts 
on implementing strategies to simplify the treatment of 
PHC users without compromising their clinical status.
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